Bell M D D
Intensive Care, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK.
J Med Ethics. 2003 Jun;29(3):176-81. doi: 10.1136/jme.29.3.176.
The imbalance between supply of organs for transplantation and demand for them is widening. Although the current international drive to re-establish procurement via non-heart beating organ donation/donor (NHBOD) is founded therefore on necessity, the process may constitute a desirable outcome for patient and family when progression to brain stem death (BSD) does not occur and conventional organ retrieval from the beating heart donor is thereby prevented. The literature accounts of this practice, however, raise concerns that risk jeopardising professional and public confidence in the broader transplant programme. This article focuses on these clinical, ethical, and legal issues in the context of other approaches aimed at increasing donor numbers. The feasibility of introducing such an initiative will hinge on the ability to reassure patients, families, attendant staff, professional bodies, the wider public, law enforcement agencies, and the media that practitioners are working within explicit guidelines which are both ethically and legally defensible.
移植器官供应与需求之间的不平衡正在加剧。因此,尽管当前国际上通过非心脏跳动器官捐献/供体(NHBOD)重新建立器官获取渠道的努力是出于必要,但当未进展到脑干死亡(BSD)从而无法从心脏跳动的供体进行传统器官摘取时,这一过程对于患者及其家属而言可能会是一个理想的结果。然而,关于这种做法的文献记载引发了人们的担忧,即可能会危及专业人士和公众对更广泛移植项目的信心。本文将在旨在增加供体数量的其他方法的背景下,重点探讨这些临床、伦理和法律问题。引入这样一项举措的可行性将取决于能否让患者、家属、医护人员、专业团体、广大公众、执法机构和媒体放心,即从业者是在明确的、在伦理和法律上都站得住脚的指导方针内开展工作。